Results 201 to 210 of about 26,471 (221)
Some of the next articles are maybe not open access.
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Nature Reviews Clinical Oncology, 2021Mary Beth Beasley +2 more
exaly
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Coelho Barata, Brian I Rini
exaly
The role of the microbiome in cancer development and therapy
Ca-A Cancer Journal for Clinicians, 2017Aadra P Bhatt, Matthew R Redinbo
exaly
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Ca-A Cancer Journal for Clinicians, 2017Fernanda G Herrera +2 more
exaly
Immunotherapy of cancer in 2012
Ca-A Cancer Journal for Clinicians, 2012Lisa H Butterfield, Ahmad A Tarhini
exaly
Pregnancy and immune thrombocytopenic purpura
American Journal of Obstetrics and Gynecology, 1984C J, Wahbeh +3 more
openaire +2 more sources
Blueprint for cancer research: Critical gaps and opportunities
Ca-A Cancer Journal for Clinicians, 2021exaly
[Immune thrombocytopenic purpura].
Recenti progressi in medicina, 1986A, Cajozzo +4 more
openaire +1 more source

